Published in JAMA on December 26, 2001
Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA (2012) 4.76
ENT assessment in the integrated management of candidate for (maxillary) sinus lift. Acta Otorhinolaryngol Ital (2008) 1.71
Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc (2011) 1.36
Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol (2011) 1.30
Intranasal corticosteroids in management of acute sinusitis: a systematic review and meta-analysis. Ann Fam Med (2012) 1.04
Measures of health-related quality of life for adults with acute sinusitis. A systematic review. J Gen Intern Med (2003) 1.03
Canadian guidelines for acute bacterial rhinosinusitis: clinical summary. Can Fam Physician (2014) 0.95
Treatment of congestion in upper respiratory diseases. Int J Gen Med (2010) 0.84
Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. Int Forum Allergy Rhinol (2014) 0.82
Drug management in chronic rhinosinusitis: identification of the needs. Ther Clin Risk Manag (2007) 0.80
Therapeutic targets in rhinosinusitis: infection or inflammation? Medscape J Med (2008) 0.76
Adding intranasal fluticasone to cefuroxime resolved acute rhinosinusitis. ACP J Club (2002) 0.75
Efficacy of intranasal corticosteroids for acute sinusitis. JAMA (2002) 0.75
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62
Evaluating the yield of medical tests. JAMA (1982) 14.05
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Case-finding instruments for depression in primary care settings. Ann Intern Med (1995) 6.93
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med (1997) 5.80
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med (1996) 5.51
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
STUDIES ON THE MOLECULAR WEIGHT OF DIPHTHERIA TOXIN, ANTITOXIN, AND THEIR REACTION PRODUCTS. J Exp Med (1940) 4.51
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
The rational clinical examination. Is this patient hypovolemic? JAMA (1999) 4.24
Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA (1993) 4.23
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
The kinetics of reversible tight-binding inhibition. Methods Enzymol (1979) 4.13
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med (1994) 3.32
Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA (1995) 3.27
The rational clinical examination. Does this patient have abdominal aortic aneurysm? . JAMA (1999) 3.22
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract (2001) 3.21
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med (1995) 2.75
The rational clinical examination. Is this patient having a myocardial infarction? JAMA (1998) 2.66
The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA (2001) 2.62
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Knowledge and attitudes about depression among non-generalists and generalists. J Fam Pract (1997) 2.51
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49
A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med (1995) 2.44
Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care (2001) 2.27
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol (1999) 2.24
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med (1992) 2.21
Spore Formation among the Anaerobic Bacteria: I. The Formation of Spores by Clostridium sporogenes in Nutrient Agar Media. J Bacteriol (1941) 2.16
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA (1999) 2.08
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1997) 2.08
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol (1996) 2.07
Measuring shoulder function with the Shoulder Pain and Disability Index. J Rheumatol (1995) 2.07
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06
Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol (1990) 2.06
Does the clinical examination predict airflow limitation? JAMA (1995) 2.05
The last word on GUSTO, for now. Ann Intern Med (1994) 2.02
Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med (1987) 1.98
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J (1990) 1.90
Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med (1994) 1.90
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev (2003) 1.85
Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Arch Intern Med (1997) 1.83
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation (2001) 1.83
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol (1997) 1.80
A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ (1997) 1.78
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation (1990) 1.74
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J (2000) 1.73
Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol (1985) 1.71
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol (1993) 1.70
Estimating the likelihood of significant coronary artery disease. Am J Med (1983) 1.69
Advanced coronary artery disease: Appropriate end points for trials of novel therapies. Am Heart J (2001) 1.67
Diagnosing sinusitis by X-ray: is a single Waters view adequate? J Gen Intern Med (1992) 1.67
Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation (1998) 1.66
The rational clinical examination. Does this patient have ascites? How to divine fluid in the abdomen. JAMA (1992) 1.64
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg (1996) 1.64